| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99199 |
Unlisted special service, procedure or report |
56 |
54 |
$33K |
| 0450 |
Emergency room services |
3,621 |
3,205 |
$33K |
| 71045 |
Radiologic examination, chest; single view |
1,022 |
981 |
$17K |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
509 |
466 |
$16K |
| 80053 |
Comprehensive metabolic panel |
1,782 |
1,667 |
$16K |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
1,300 |
1,173 |
$13K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
2,092 |
1,931 |
$12K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
176 |
170 |
$7K |
| 81000 |
|
915 |
874 |
$4K |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
664 |
618 |
$3K |
| 96375 |
Therapeutic injection; each additional sequential IV push |
405 |
365 |
$3K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
245 |
229 |
$2K |
| 85730 |
|
543 |
513 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
185 |
179 |
$2K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
41 |
40 |
$2K |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
160 |
154 |
$2K |
| 85610 |
|
545 |
515 |
$2K |
| 84484 |
|
530 |
497 |
$1K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
91 |
83 |
$1K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
275 |
259 |
$951.67 |
| 70450 |
Computed tomography, head or brain; without contrast material |
71 |
68 |
$778.45 |
| 83690 |
|
463 |
419 |
$685.54 |
| U0003 |
Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r |
13 |
12 |
$525.00 |
| 81025 |
|
354 |
341 |
$508.22 |
| 0250 |
|
268 |
201 |
$496.92 |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
126 |
124 |
$468.04 |
| G0481 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed |
42 |
38 |
$393.56 |
| 81002 |
|
228 |
219 |
$352.15 |
| 82150 |
|
165 |
146 |
$240.67 |
| J7030 |
Infusion, normal saline solution , 1000 cc |
113 |
107 |
$208.16 |
| 0270 |
|
262 |
212 |
$93.00 |
| J3490 |
Unclassified drugs |
563 |
461 |
$79.58 |
| 80048 |
Basic metabolic panel (calcium, ionized) |
155 |
138 |
$68.46 |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
103 |
89 |
$52.83 |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
47 |
39 |
$31.32 |
| 84703 |
|
25 |
24 |
$9.29 |
| 82550 |
|
13 |
13 |
$8.04 |
| 80076 |
|
74 |
65 |
$0.00 |
| 0272 |
|
247 |
234 |
$0.00 |
| A4649 |
Surgical supply; miscellaneous |
47 |
41 |
$0.00 |
| 83880 |
|
12 |
12 |
$0.00 |